[HTML][HTML] Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
M Alegría-Arcos, T Barbosa, F Sepúlveda… - 2022 - digital.csic.es
The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19.
M Alegría-Arcos, T Barbosa, F Sepúlveda… - Frontiers in …, 2022 - europepmc.org
The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
M Alegría-Arcos, T Barbosa… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
[PDF][PDF] Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
M Alegría-Arcos, T Barbosa, F Sepúlveda… - 2022 - researchgate.net
The recent pandemic is caused by a coronavirus (CoV), which elicits severe acute
respiratory syndrome (SARS), an infectious disease named COVID-19. Severe acute …
respiratory syndrome (SARS), an infectious disease named COVID-19. Severe acute …
[HTML][HTML] Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
M Alegría-Arcos, T Barbosa, F Sepúlveda… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
[PDF][PDF] Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
M Alegría-Arcos, T Barbosa, F Sepúlveda… - 2022 - scienceopen.com
The recent pandemic is caused by a coronavirus (CoV), which elicits severe acute
respiratory syndrome (SARS), an infectious disease named COVID-19. Severe acute …
respiratory syndrome (SARS), an infectious disease named COVID-19. Severe acute …
[PDF][PDF] Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
M Alegría-Arcos, T Barbosa, F Sepúlveda… - 2022 - ramirezlab.github.io
The recent pandemic is caused by a coronavirus (CoV), which elicits severe acute
respiratory syndrome (SARS), an infectious disease named COVID-19. Severe acute …
respiratory syndrome (SARS), an infectious disease named COVID-19. Severe acute …
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
M Alegría-Arcos, T Barbosa, F Sepúlveda… - 2022 - repositorio.uautonoma.cl
The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19.
M Alegría-Arcos, T Barbosa, F Sepúlveda… - Frontiers in …, 2022 - europepmc.org
The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …